Panacea Life Sciences Holdings, Inc. Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount (Deprecated 2018-01-31)
Panacea Life Sciences Holdings, Inc. (PLSH) reported Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount (Deprecated 2018-01-31) of $1.05 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-02.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLossOtherThanTemporaryImpairmentsAmount · last filed 2018-04-02
- Panacea Life Sciences Holdings, Inc. marketable securities, realized loss, other than temporary impairments, amount (deprecated 2018-01-31) for fiscal 2017 was $1.05M, a 25635.29% increase from fiscal 2016.
- Panacea Life Sciences Holdings, Inc. marketable securities, realized loss, other than temporary impairments, amount (deprecated 2018-01-31) for fiscal 2016 was $4.08K, a 60.06% decline from fiscal 2015.
- Panacea Life Sciences Holdings, Inc. marketable securities, realized loss, other than temporary impairments, amount (deprecated 2018-01-31) for fiscal 2015 was $10.21K.
| Period end | Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount (Deprecated 2018-01-31) 12 month | Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|
| 2017-12-31 | $1.05M 10-K · filed 2018-04-02 | |
| 2016-12-31 | $4.08K 10-K · filed 2018-04-02 | $0.00 10-K · filed 2017-03-31 |
| 2015-12-31 | $10.21K 10-K · filed 2017-03-31 |